All In MedTech

Device Trial Radar · NCT05833945

Potential Use of a POCT for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center

Study of the Potential Use of a Rapid Point-of-Care Device for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center

Last checked: Nov 19, 2026Latest source record: Nov 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

355

Actual

Start

Apr 15, 2023

Primary completion

Jan 31, 2024

Study completion Apr 24, 2024

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Hospital Universitario Virgen Macarena; Hospitales Universitarios Virgen del Rocío; Hospital Universitario Torrecárdenas; Hospital Universitario Poniente; Hospital Clínico Universitario Lozano Blesa; Hospital Miguel Servet; Hospital Universitario Royo Villanova; Hospital General San Jorge; Hospital San Pedro de Logroño; Hospital Clínico Universitario de Valladolid; Hospital Universitario La Fe; Complejo Hospitalario Universitario de Albacete; Hospital de Medina del Campo; Hospital General Río Carrión; Hospital General de Segovia; Hospital del Rio Hortega
First posted
Apr 27, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Stroke is the leading cause of long-term disability and the second most common cause of death worldwide. Currently, the protocols require the imaging techniques at the hospitals to differ ischemic strokes with large vessel occlusion (LVO) from others. In this study, a duplex POC will be used in combination with an APP to identify LVO ischemic strokes in a 800 patients'cohort with pre-hospital and in-hospital blood samples.

Conditions

  • Stroke, Acute Ischemic

Interventions

  • Large Vessel Occlusion Biomarkers TestDevice

    Duplex Point of Care test to measure the concentration of biomarkers associated to Large Vessel Occlusion in blood samples used in combination with an APP.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of the diagnosis accuracy of the algorithm LVOCheck (Specificity and sensibility)Time frame: 6 months

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Complejo Hospitalario Universitario Albacete

    Albacete, Spain

  • Hospital Universitario Poniente

    Almería, Spain

  • Hospital Universitario Torrecárdenas

    Almería, Spain

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.